Thus, the question arises as to whether a FLT3 inhibitor could be effective on NSCLC cells when DNA repair genes are essential for the survival of NSCLC cells, even those with wild-type FLT3 [14,30,31,32]. This evidence concerns the gene FLT3 and non-small cell lung carcinoma.